Cancer clinical trials are a critically important step on the pathway for new or improved treatments to make their way to patients in clinics and hospitals in towns and cities across the country. Patients and their loved ones are relying on these rigorous studies to determine whether promising new therapies and approaches might extend how long they live or improve their quality of life. For many years, a steady number of patients with cancer, approximately 5%, have participated in cancer clinical trials.
Presidential Innovation Fellows
Built on the lessons learned during the pilot phase of the Digital Acquisitions Accelerator, the accompanying playbook examines the current acquisition landscape and provides an approach to procuring custom software solutions. Our goal is to make the government a smarter and more informed buyer of digital products and services. The playbook has four main sections: Overview Case studies Process Primers The overview section provides background on digital acquisitions and highlights some ways to lower risk when planning this type of activity.